These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26069294)

  • 1. Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.
    Shroff R; Aitkenhead H; Costa N; Trivelli A; Litwin M; Picca S; Anarat A; Sallay P; Ozaltin F; Zurowska A; Jankauskiene A; Montini G; Charbit M; Schaefer F; Wühl E;
    J Am Soc Nephrol; 2016 Jan; 27(1):314-22. PubMed ID: 26069294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
    Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
    Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial.
    Ruggiero B; Trillini M; Tartaglione L; Rotondi S; Perticucci E; Tripepi R; Aparicio C; Lecchi V; Perna A; Peraro F; Villa D; Ferrari S; Cannata A; Mazzaferro S; Mallamaci F; Zoccali C; Bellasi A; Cozzolino M; Remuzzi G; Ruggenenti P; Kohan DE;
    Am J Kidney Dis; 2019 Sep; 74(3):338-350. PubMed ID: 31027883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum 1,25-dihydroxyvitamin D Better Reflects Renal Parameters Than 25-hydoxyvitamin D in Patients with Glomerular Diseases.
    Chung S; Kim M; Koh ES; Hwang HS; Chang YK; Park CW; Kim SY; Chang YS; Hong YA
    Int J Med Sci; 2017; 14(11):1080-1087. PubMed ID: 29104461
    [No Abstract]   [Full Text] [Related]  

  • 5. Aliskiren add-on therapy effectively reduces proteinuria in chronic kidney disease: an open-label prospective trial.
    Wu MT; Tung SC; Hsu KT; Lee CT
    J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):271-7. PubMed ID: 23223162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
    Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
    J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Proteinuria Lowering by Angiotensin-Converting Enzyme Inhibition Predicts Renal Survival in Children with CKD.
    van den Belt SM; Heerspink HJL; Gracchi V; de Zeeuw D; Wühl E; Schaefer F;
    J Am Soc Nephrol; 2018 Aug; 29(8):2225-2233. PubMed ID: 29930161
    [No Abstract]   [Full Text] [Related]  

  • 8. Strict blood-pressure control and progression of renal failure in children.
    ; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
    N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
    Fernández-Juárez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Lahera V; Casas L; Oliva J;
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1870-6. PubMed ID: 24135218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum 25-hydroxyvitamin D concentration is not associated with glomerular filtration rate in a predominantly obese otherwise healthy population.
    Naderpoor N; Mousa A; de Courten MPJ; Scragg R; Ranasinha S; de Courten B
    J Steroid Biochem Mol Biol; 2017 Oct; 173():253-257. PubMed ID: 27687738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment.
    de Goeij MC; Liem M; de Jager DJ; Voormolen N; Sijpkens YW; Rotmans JI; Boeschoten EW; Dekker FW; Grootendorst DC; Halbesma N;
    Nephron Clin Pract; 2012; 121(1-2):c73-82. PubMed ID: 23128440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role for Protein Restriction in Addition to Renin-Angiotensin-Aldosterone System Inhibitors in the Management of CKD.
    Koppe L; Fouque D
    Am J Kidney Dis; 2019 Feb; 73(2):248-257. PubMed ID: 30149957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In chronic kidney disease, serum α-Klotho is related to serum bicarbonate and proteinuria.
    Hage V; Pelletier S; Dubourg L; Drai J; Cuerq C; Lemoine S; Hadj-Aissa A; Laville M; Fouque D
    J Ren Nutr; 2014 Nov; 24(6):390-4. PubMed ID: 25193108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study.
    Tylicki L; Jakubowska A; Lizakowski S; Świetlik D; Rutkowski B
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):145-52. PubMed ID: 25324423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of Oxidative Stress in Chronic Kidney Disease Does Not Increase Circulating α-Klotho Concentrations.
    Adema AY; van Ittersum FJ; Hoenderop JG; de Borst MH; Nanayakkara PW; Ter Wee PM; Heijboer AC; Vervloet MG;
    PLoS One; 2016; 11(1):e0144121. PubMed ID: 26807718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial stiffness and 25-hydroxyvitamin D levels in chronic kidney disease patients.
    Akdam H; Alp A
    Rev Assoc Med Bras (1992); 2017 Oct; 63(10):910-916. PubMed ID: 29267494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of some medications given to CKD patients on vitamin D levels.
    Yuste C; Quiroga B; de Vinuesa SG; Goicoechea MA; Barraca D; Verdalles U; Luño J
    Nefrologia; 2015; 35(2):150-6. PubMed ID: 26300508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproteinuria Effect of Calcitriol in Patients With Chronic Kidney Disease and Vitamin D Deficiency: A Randomized Controlled Study.
    Wu CC; Liao MT; Hsiao PJ; Lu CL; Hsu YJ; Lu KC; Chu P
    J Ren Nutr; 2020 May; 30(3):200-207. PubMed ID: 31704188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin-angiotensin-aldosterone system among patients with obesity and proteinuria.
    Morales E; Gutiérrez E; Caro J; Sevillano A; Rojas-Rivera J; Praga M
    Nefrologia; 2015; 35(6):554-61. PubMed ID: 26519114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.